Ferras Alwan is a Consultant Haematologist at Imperial College NHS Trust, specialising in blood clotting and bleeding disorders. Imperial College is one of the largest NHS trusts in the UK, encompassing five major hospitals; Charing Cross Hospital, Hammersmith Hospital, The Western Eye Hospital, Queen Charlotte’s and Chelsea Maternity Hospital, and St Mary’s Hospital, and within the trust, Dr Alwan is head of service for haemostasis and thrombosis. As the tertiary haematology centre for West London, this is a busy role in which he sees new patients, requests for a second opinion and supervises the ongoing management of patients with chronic haemostastic conditions or complex care needs. Dr Alwan is also Centre Director of the Imperial Haemophilia Comprehensive Care Centre, one of only five in London designated as having Comprehensive Care status and so permitted to treat rare and complex bleeding disorders such as haemophilia, von Willebrand Disease and other inherited bleeding conditions.
In addition to his clinical work, Dr Alwan is the Principal Investigator for a number of clinical trials evaluating new treatment options in thrombosis, haemophilia and von Willebrand Disease.
Background
Dr Alwan attended Barts and the London School of Medicine for undergraduate training during which he also undertook an intercalated degree in Community Health Sciences, focusing on medical education. His post graduate training in haematology took place in North and Central London, predominately between University College London Hospital and Great Ormond Street Hospital, ensuring a wide exposure to rare and common haematological conditions.
Dr Alwan took time out during his postgraduate training to undertake research towards a PhD at the UCL Haemostasis Research Unit. His thesis looked at better understanding the prognostic factors affecting outcomes in Thrombotic Thrombocytopenic Purpura (TTP) and work performed for his PhD has been presented at international conferences in Philadelphia (International Society on Thrombosis and Haemostasis), Copenhagen (European Haematology Association), Berlin (International Society on Thrombosis and Haemostasis), Atlanta (American Society of Hematology) and San Diego (American Society of Hematology). His publications have garnered hundreds of citations and their findings and suggestions referenced in both the British and International Society on Thrombosis and Haemostasis (ISTH) TTP treatment guidelines.